7-28956050-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_014817.4(TRIL):​c.1997G>A​(p.Gly666Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000179 in 1,550,120 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G666R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00018 ( 2 hom. )

Consequence

TRIL
NM_014817.4 missense

Scores

3
2
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.598
Variant links:
Genes affected
TRIL (HGNC:22200): (TLR4 interactor with leucine rich repeats) TRIL is a component of the TLR4 (MIM 603030) complex and is induced in a number of cell types by lipopolysaccharide (LPS) (Carpenter et al., 2009 [PubMed 19710467]).[supplied by OMIM, Apr 2010]
CPVL-AS2 (HGNC:56138): (CPVL antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020411104).
BS2
High Homozygotes in GnomAdExome4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRILNM_014817.4 linkc.1997G>A p.Gly666Glu missense_variant Exon 1 of 1 ENST00000539664.3 NP_055632.2 Q7L0X0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRILENST00000539664.3 linkc.1997G>A p.Gly666Glu missense_variant Exon 1 of 1 6 NM_014817.4 ENSP00000479256.1 Q7L0X0

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152244
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000349
AC:
51
AN:
146198
AF XY:
0.000463
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000789
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000172
Gnomad OTH exome
AF:
0.000691
GnomAD4 exome
AF:
0.000183
AC:
256
AN:
1397758
Hom.:
2
Cov.:
30
AF XY:
0.000224
AC XY:
155
AN XY:
690618
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31920
American (AMR)
AF:
0.000109
AC:
4
AN:
36678
Ashkenazi Jewish (ASJ)
AF:
0.0000396
AC:
1
AN:
25240
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36192
South Asian (SAS)
AF:
0.00143
AC:
114
AN:
79710
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40170
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5678
European-Non Finnish (NFE)
AF:
0.0000987
AC:
107
AN:
1083846
Other (OTH)
AF:
0.000394
AC:
23
AN:
58324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000144
AC:
22
AN:
152362
Hom.:
0
Cov.:
34
AF XY:
0.000175
AC XY:
13
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41592
American (AMR)
AF:
0.000131
AC:
2
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68038
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000217
Hom.:
0
Bravo
AF:
0.0000982
ExAC
AF:
0.000213
AC:
24
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 27, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1997G>A (p.G666E) alteration is located in exon 1 (coding exon 1) of the TRIL gene. This alteration results from a G to A substitution at nucleotide position 1997, causing the glycine (G) at amino acid position 666 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.073
T
BayesDel_noAF
Uncertain
0.090
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Benign
0.074
T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.020
T
MutationAssessor
Benign
0.81
L
PhyloP100
0.60
PrimateAI
Pathogenic
0.91
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.16
B
Vest4
0.28
MVP
0.24
GERP RS
3.2
Varity_R
0.17
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs562686571; hg19: chr7-28995666; API